[Renal bone disease].

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Renal bone disease is a significant complication of chronic kidney failure.
• Pathogenesis involves hypophosphatemia, hypocalcemia, and calcitriol deficiency as kidney function declines.
• The condition presents with either high or low bone turnover, including dynamic bone disease and extraosseous calcifications.

Purpose of the Study:

• To outline the complex pathogenesis of renal bone disease.
• To review current therapeutic strategies for managing renal bone disease.
• To highlight emerging treatment trends for renal bone disease.

Main Methods:

• Literature review of pathogenetic mechanisms and treatment options.
• Analysis of current therapeutic interventions including phosphate binders, calcium supplementation, and vitamin D metabolites.
• Discussion of surgical interventions and novel therapeutic approaches.

Main Results:

• Renal bone disease develops due to mineral and vitamin D imbalances in chronic kidney disease.
• Current treatments focus on correcting these imbalances and managing hyperparathyroidism.
• The dynamic bone disease subtype lacks established treatments, emphasizing prevention.

Conclusions:

• Effective management of renal bone disease requires addressing hypophosphatemia, hypocalcemia, and vitamin D deficiency.
• Novel treatments like non-calcium phosphate binders, vitamin D analogs, and calcimimetics show promise.
• Further research is needed for the dynamic bone disease subtype.